Abstract
“SANDS provides important data that suggest additional benefits of aggressive lipid and blood pressure targets in this high-risk population compared with standard goals.” Jerome L Fleg† †Author for correspondence: Division of Cardiovascular Diseases, National Heart, Lung & Blood Institute, 6701 Rockledge Drive, Room 8150, Bethesda, MD 20892, USA Tel.: +1 301 435 0420 Fax: +1 301 480 3667 flegj@nhlbi.nih.gov
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
